{"id":890133,"date":"2025-09-29T09:00:14","date_gmt":"2025-09-29T13:00:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/"},"modified":"2025-09-29T09:00:14","modified_gmt":"2025-09-29T13:00:14","slug":"agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/","title":{"rendered":"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing"},"content":{"rendered":"

<\/p>\n

Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing<\/b><\/p>\n

\nHelping Biopharma Labs Reach New Heights in Analytical Performance<\/p>\n

SANTA CLARA, Calif.–(BUSINESS WIRE<\/a>)–Agilent Technologies Inc.<\/a> (NYSE: A) today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications. The Agilent Altura Ultra Inert HPLC Columns<\/a> set a new standard in liquid chromatography performance, providing the reliability and efficiency biopharmaceutical companies need for the most demanding applications, including peptide GLP-1 and oligonucleotide therapeutic development and quality control.<\/p>\n

\nThe rapidly evolving biopharma market faces unique challenges in the pursuit of innovative biotherapeutics. High-performance columns and lower limits of detection are required for biopharma labs to accelerate the discovery of these peptide- and oligonucleotide-based therapeutics and meet increasingly rigorous regulatory expectations.<\/p>\n

\nAltura HPLC columns unlock the full separation potential of the stationary phase, delivering superior chromatographic performance \u2014 faster conditioning, improved peak shape, and enhanced sensitivity \u2014 for even the most challenging analytes. Agilent\u2019s in-house expertise in inert coating, exemplified by the proprietary Ultra Inert technology featured in Altura HPLC columns, delivers consistent, robust performance under demanding operating conditions. This innovation is central to Agilent\u2019s long-term strategy for LC column development.<\/p>\n

\n\u201cCustomers producing complex therapeutics are under growing pressure to detect and characterize impurities with greater precision,\u201d said David Edwards, vice president and general manager of the Chemistries and Supplies Division at Agilent. \u201cTo support their efforts, Agilent developed the Altura line of inert HPLC columns, which demonstrate up to twice the sensitivity and three times the signal-to-noise ratio compared to competitor columns. When paired with the Agilent 1290 Infinity III Bio LC, up to 30 times higher peak area can be obtained. Named after the Spanish word for \u2018height,\u2019 Altura reflects our commitment to help customers reach new heights in analytical performance and scientific discovery.\u201d<\/p>\n

\n\u201cThe Altura HILIC-Z HPLC column substantially reduced the undesired analyte-surface interactions in the analysis of GLP-1 receptor agonist drug products,\u201d said Piotr Alvarez, senior scientist at RIC Group, in Belgium. \u201cWe have observed at least a 30 percent increase in sensitivity and reduction in peak tailing for the analysis of acidic peptides and excipients.\u201d<\/p>\n

\nThe Altura line of LC columns further expands Agilent\u2019s broad range of solutions supporting a fully inert sample flow path. A key addition to their inert flow path portfolio, this launch reinforces Agilent\u2019s focus on delivering innovative products to drive the development and production of exceptionally high-quality therapeutics.<\/p>\n

About Agilent Technologies<\/b><\/p>\n

\nAgilent Technologies Inc., (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent\u2019s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers’ most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com<\/a>. To receive the latest Agilent news, please subscribe to the Agilent Newsroom<\/a>. Follow Agilent on LinkedIn<\/a> and Facebook<\/a>.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250929316398\/en\/<\/a><\/span><\/p>\n

Media Contact
\n
<\/b>Naomi Goumillout
\n
Agilent Technologies
\n
978-314-1862
\n
naomi.goumillout@agilent.com<\/a><\/p>\n

KEYWORDS:<\/b> California Belgium Europe United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Clinical Trials Research Pharmaceutical Science Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing Helping Biopharma Labs Reach New Heights in Analytical Performance SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications. The Agilent Altura Ultra Inert HPLC Columns set a new standard in liquid chromatography performance, providing the reliability and efficiency biopharmaceutical companies need for the most demanding applications, including peptide GLP-1 and oligonucleotide therapeutic development and quality control. The rapidly evolving biopharma market faces unique challenges in the pursuit of innovative biotherapeutics. High-performance columns and lower limits of detection are required for biopharma labs to accelerate the discovery … <\/p>\n

Continue reading “Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-890133","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAgilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing Helping Biopharma Labs Reach New Heights in Analytical Performance SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications. The Agilent Altura Ultra Inert HPLC Columns set a new standard in liquid chromatography performance, providing the reliability and efficiency biopharmaceutical companies need for the most demanding applications, including peptide GLP-1 and oligonucleotide therapeutic development and quality control. The rapidly evolving biopharma market faces unique challenges in the pursuit of innovative biotherapeutics. High-performance columns and lower limits of detection are required for biopharma labs to accelerate the discovery … Continue reading "Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-29T13:00:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929316398r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing\",\"datePublished\":\"2025-09-29T13:00:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/\"},\"wordCount\":563,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250929316398r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/\",\"name\":\"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250929316398r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-09-29T13:00:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250929316398r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250929316398r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/","og_locale":"en_US","og_type":"article","og_title":"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing - Market Newsdesk","og_description":"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing Helping Biopharma Labs Reach New Heights in Analytical Performance SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications. The Agilent Altura Ultra Inert HPLC Columns set a new standard in liquid chromatography performance, providing the reliability and efficiency biopharmaceutical companies need for the most demanding applications, including peptide GLP-1 and oligonucleotide therapeutic development and quality control. The rapidly evolving biopharma market faces unique challenges in the pursuit of innovative biotherapeutics. High-performance columns and lower limits of detection are required for biopharma labs to accelerate the discovery … Continue reading \"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-29T13:00:14+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929316398r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing","datePublished":"2025-09-29T13:00:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/"},"wordCount":563,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929316398r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/","name":"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929316398r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-09-29T13:00:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929316398r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929316398r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-introduces-the-altura-line-of-inert-hplc-columns-for-superior-results-in-biotherapeutic-testing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/890133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=890133"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/890133\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=890133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=890133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=890133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}